FGFR2 fusion as the key to targeted therapy - a case report with a diagnostic turning point. (PubMed, Klin Onkol) - Aug 29, 2026 - "The dynamics of the clinical picture require continuous reassessment, repeated biopsies, and he utilization of modern molecular profiling methods (NGS) to ensure the most accurate diagnosis and optimal treatment strategy. The journey toward targeted therapy can be arduous and may be preceded by immunotherapy with a favorable clinical response."
IO biomarker • Journal • Biliary Cancer • Cholangiocarcinoma • Lung Adenocarcinoma • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor • FGFR2 • FGFR3 • TACC3
|
|
Jozef Bocko; Marie Drösslerova; Miloš Pešek
|